Guided Therapeutics Inc
OTC:GTHP
Guided Therapeutics Inc
OTC:GTHP
Price:
0.2795
USD
-0.89%
Market Cap:
$23.4m
Balance Sheet
Balance Sheet Decomposition
Guided Therapeutics Inc
Guided Therapeutics Inc
Balance Sheet Decomposition is not available for
Guided Therapeutics Inc
Guided Therapeutics Inc
Balance Sheet
Guided Therapeutics Inc
Guided Therapeutics Inc
Currency: USD
| Dec-2001 | Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
9
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
2
|
1
|
0
|
|
| Cash Equivalents |
9
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
2
|
1
|
0
|
|
| Total Receivables |
1
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
1
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Other Current Assets |
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
12
|
3
|
3
|
2
|
1
|
1
|
0
|
0
|
0
|
3
|
3
|
2
|
2
|
2
|
2
|
1
|
0
|
0
|
1
|
1
|
2
|
3
|
1
|
1
|
|
| PP&E Net |
1
|
1
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
1
|
1
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
1
|
1
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
2
|
|
| Intangible Assets |
4
|
4
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
17
N/A
|
7
-55%
|
7
-10%
|
3
-58%
|
2
-38%
|
1
-29%
|
1
-21%
|
1
-10%
|
1
-10%
|
4
+396%
|
4
+10%
|
3
-19%
|
3
-5%
|
3
-9%
|
3
-17%
|
1
-41%
|
0
-72%
|
0
-41%
|
1
+392%
|
1
+14%
|
2
+51%
|
3
+65%
|
2
-50%
|
1
-17%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
3
|
3
|
3
|
3
|
2
|
2
|
2
|
2
|
|
| Accrued Liabilities |
1
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
3
|
4
|
3
|
3
|
3
|
1
|
1
|
1
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
2
|
1
|
1
|
1
|
1
|
0
|
1
|
0
|
2
|
2
|
2
|
2
|
2
|
2
|
1
|
1
|
0
|
1
|
1
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
8
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
3
|
3
|
2
|
0
|
1
|
0
|
1
|
|
| Other Current Liabilities |
0
|
1
|
2
|
5
|
5
|
8
|
2
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
1
|
1
|
|
| Total Current Liabilities |
2
|
2
|
4
|
6
|
7
|
11
|
4
|
9
|
13
|
3
|
3
|
2
|
2
|
5
|
5
|
9
|
12
|
11
|
12
|
9
|
6
|
5
|
5
|
6
|
|
| Long-Term Debt |
0
|
0
|
1
|
0
|
0
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
3
|
1
|
8
|
5
|
5
|
3
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
3
N/A
|
2
-11%
|
5
+118%
|
7
+29%
|
8
+22%
|
13
+59%
|
6
-53%
|
9
+44%
|
13
+51%
|
3
-77%
|
3
-2%
|
2
-17%
|
3
+46%
|
8
+119%
|
8
+8%
|
11
+33%
|
20
+84%
|
16
-19%
|
18
+13%
|
12
-33%
|
7
-39%
|
6
-17%
|
5
-12%
|
6
+14%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
6
|
6
|
5
|
5
|
5
|
5
|
4
|
3
|
2
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
2
|
4
|
4
|
6
|
10
|
7
|
6
|
6
|
|
| Retained Earnings |
39
|
48
|
51
|
60
|
63
|
68
|
65
|
69
|
76
|
78
|
85
|
92
|
103
|
113
|
123
|
128
|
139
|
138
|
140
|
140
|
142
|
147
|
151
|
154
|
|
| Additional Paid In Capital |
48
|
48
|
48
|
52
|
52
|
52
|
56
|
59
|
62
|
80
|
87
|
93
|
102
|
108
|
115
|
116
|
117
|
118
|
119
|
123
|
127
|
138
|
141
|
143
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
14
N/A
|
5
-64%
|
2
-67%
|
4
N/A
|
6
-67%
|
11
-84%
|
5
+57%
|
8
-55%
|
12
-58%
|
1
N/A
|
1
+46%
|
1
-23%
|
0
N/A
|
4
-3 964%
|
6
-24%
|
9
-67%
|
19
-109%
|
16
+18%
|
17
-7%
|
11
+36%
|
5
+50%
|
3
+47%
|
4
-32%
|
5
-28%
|
|
| Total Liabilities & Equity |
17
N/A
|
7
-55%
|
7
-10%
|
3
-58%
|
2
-38%
|
1
-29%
|
1
-21%
|
1
-10%
|
1
-10%
|
4
+396%
|
4
+10%
|
3
-19%
|
3
-5%
|
3
-9%
|
3
-17%
|
1
-41%
|
0
-72%
|
0
-41%
|
1
+392%
|
1
+14%
|
2
+51%
|
3
+65%
|
2
-50%
|
1
-17%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
13
|
14
|
49
|
54
|
65
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
